Search hospitals
>
New York
>
New York
Mount Sinai West
Claim this profile
New York, New York 10019
Global Leader in Breast Cancer
Global Leader in Breast cancer
Conducts research for Lung Cancer
Conducts research for Pancreatic Cancer
Conducts research for Cancer
113 reported clinical trials
29 medical researchers
Summary
Mount Sinai West is a medical facility located in New York, New York. This center is recognized for care of Breast Cancer, Breast cancer, Lung Cancer, Pancreatic Cancer, Cancer and other specialties. Mount Sinai West is involved with conducting 113 clinical trials across 191 conditions. There are 29 research doctors associated with this hospital, such as Thomas Marron, MD PhD, Amy D. Tiersten, Joanne V Loewy, and Stephanie Blank, MD.
Area of expertise
Breast Cancer
Mount Sinai West has run 34 trials for Breast Cancer. Some of their research focus areas include:
Breast Cancer
Mount Sinai West has run 20 trials for Breast cancer. Some of their research focus areas include:
Top PIs
Thomas Marron, MD PhD
Icahn School of Medicine at Mount Sinai
3 years of reported clinical research
Amy D. Tiersten
Icahn School of Medicine at Mount Sinai Division of Hematology and Medical Oncology
2 years of reported clinical research
Joanne V Loewy
Louis Armstrong Center for Music and Medicine at Mount Sinai Health System
6 years of reported clinical research
Stephanie Blank, MD
Mount Sinai Hospital
3 years of reported clinical research
Clinical Trials running at Mount Sinai West
Breast Cancer
Pancreatic Cancer
Ovarian Cancer
Breast cancer
Cancer
Lung Cancer
Anal Cancer
Heart Failure
Prostate Cancer
Stroke
Abemaciclib + Bicalutamide
for Breast Cancer
This is an open label multicenter, Phase IB/II Study of Abemaciclib in Combination with Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer
Recruiting
3 awards
Phase 1 & 2
18 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting
2 awards
Phase 3
19 criteria
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting
2 awards
Phase 3
12 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Mount Sinai West?
Mount Sinai West is a medical facility located in New York, New York. This center is recognized for care of Breast Cancer, Breast cancer, Lung Cancer, Pancreatic Cancer, Cancer and other specialties. Mount Sinai West is involved with conducting 113 clinical trials across 191 conditions. There are 29 research doctors associated with this hospital, such as Thomas Marron, MD PhD, Amy D. Tiersten, Joanne V Loewy, and Stephanie Blank, MD.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.